Sinofn Health
Sinofn Health
When choosing between custom amino acids and general protein sources, the strategic focus shifts from mere nutrition to metabolic intervention. While complete proteins provide a broad spectrum of nitrogen sources, isolated amino acids—the focus of our high-end manufacturing—offer targeted delivery systems.
At SINOFN, we specialize in identifying the threshold where raw protein ingestion becomes insufficient for clinical or performance needs, requiring the pinpoint accuracy of specific amino acid precursors to stimulate anabolic pathways or mitigate metabolic deficiencies (such as in PKU management).
In an era of global volatility, our "China Factory 4.0" approach integrates AI-driven inventory management with automated batch synthesis. This ensures that whether you are sourcing bulk commodities or specialized small-batch clinical ingredients, the lead times remain competitive, and quality variance is virtually eliminated.
During her clinical work, Mrs. Liu witnessed the lifelong struggles of PKU children. Driven by this, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods, bridging the gap between high-cost clinical needs and accessible nutrition. Our legacy is built on the philosophy: "We measure success not just in revenue, but in lives improved through accessible science."
Led by Dr. Zhang Ying (Chinese Academy of Sciences Postdoc) and Dr. Tan Shengjie (Peking University Medical School), our team manages complex formulation development. With the guidance of Hans van Dijk (Netherlands) for EU regulatory alignment, we provide a global standard for your formulations.
Standard proteins are broad. Custom amino acids allow for surgical precision in nutritional therapy, sports recovery, and mitigating specific metabolic disorders like PKU.
We are ISO22000, HACCP, and FSSC 22000 certified. Our regulatory team ensures compliance with global standards (FDA, EU, China) for seamless international distribution.
Yes. Our R&D center provides pilot-scale prototyping for tablets, capsules, and liquids, allowing for rapid iteration before full-scale manufacturing.
